Sumitomo Pharma Revenue

In the fiscal year ending March 31, 2025, Sumitomo Pharma had annual revenue of 398.83B JPY with 26.79% growth. Sumitomo Pharma had revenue of 105.65B in the quarter ending March 31, 2025, with 32.84% growth.

Revenue

398.83B

Revenue Growth

+26.79%

P/S Ratio

0.80

Revenue / Employee

80.09M

Employees

4,980

Market Cap

319.82B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%
Mar 31, 2021	515.95B	33.22B	6.88%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Daiichi Sankyo Company	1,886.26B
Takeda Pharmaceutical Company	4,581.55B
HOYA Corporation	869.37B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Olympus	997.33B

Revenue Rankings